These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26906163)

  • 41. Adding artesunate to sulphadoxine-pyrimethamine greatly improves the treatment efficacy in children with uncomplicated falciparum malaria on the coast of Benin, West Africa.
    Nahum A; Erhart A; Gazard D; Agbowai C; Van Overmeir C; van Loen H; Menten J; Akogbeto M; Coosemans M; Massougbodji A; D'Alessandro U
    Malar J; 2007 Dec; 6():170. PubMed ID: 18154655
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prophylaxis of toxoplasmosis infection with pyrimethamine/sulfadoxine (Fansidar) in bone marrow transplant recipients.
    Foot AB; Garin YJ; Ribaud P; Devergie A; Derouin F; Gluckman E
    Bone Marrow Transplant; 1994 Aug; 14(2):241-5. PubMed ID: 7994239
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adherence to antimalarial combination therapy with sulfadoxine-pyrimethamine and artesunate in rural Tanzania.
    Kachur SP; Khatib RA; Kaizer E; Fox SS; Abdulla SM; Bloland PB
    Am J Trop Med Hyg; 2004 Dec; 71(6):715-22. PubMed ID: 15642960
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Frequency of persistent or transitory serologic negative values in infants with congenital toxoplasmosis. Experience of the Reims Toxoplasmosis Group (1980-1997)].
    Chemla C; Villena I; Aubert D; Leroux B; Dupouy D; Pinon JM
    Presse Med; 2002 Feb; 31(5):232. PubMed ID: 11878142
    [No Abstract]   [Full Text] [Related]  

  • 45. Central nervous system toxoplasmosis in adult Ethiopians.
    Amogne W; Teshager G; Zenebe G
    Ethiop Med J; 2006 Apr; 44(2):113-20. PubMed ID: 17447372
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fansidar for malaria prophylaxis.
    Kissane D
    Aust Fam Physician; 1985 Aug; 14(8):738. PubMed ID: 3901990
    [No Abstract]   [Full Text] [Related]  

  • 47. [Treatment of recurrent congenital ocular toxoplasmosis. Our initial experience with Fansidar].
    Comte P; Verin P; Le Bras M
    Bull Soc Ophtalmol Fr; 1989 Apr; 89(4):567-8, 571-2. PubMed ID: 2686844
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Artesunate plus sulfadoxine-pyrimethamine in the treatment of uncomplicated Plasmodium falciparum malaria during pregnancy in eastern Sudan.
    Adam I; Ali DM; Abdalla MA
    Trans R Soc Trop Med Hyg; 2006 Jul; 100(7):632-5. PubMed ID: 16436287
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Amodiaquine, sulfadoxine-pyrimethamine, and combination therapy for uncomplicated falciparum malaria: a randomized controlled trial from Burkina Faso.
    Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Lankoande M; Ouedraogo JB; Rosenthal PJ
    Am J Trop Med Hyg; 2005 Nov; 73(5):826-32. PubMed ID: 16282288
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sustained clinical efficacy of sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Malawi after 10 years as first line treatment: five year prospective study.
    Plowe CV; Kublin JG; Dzinjalamala FK; Kamwendo DS; Mukadam RA; Chimpeni P; Molyneux ME; Taylor TE
    BMJ; 2004 Mar; 328(7439):545. PubMed ID: 14757706
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of pyrimethamine/sulfadoxine in the prevention of toxoplasmic encephalitis relapses and Pneumocystis carinii pneumonia in HIV-infected patients.
    Ruf B; Schürmann D; Bergmann F; Schüler-Maué W; Grünewald T; Gottschalk HJ; Witt H; Pohle HD
    Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):325-9. PubMed ID: 8354297
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial.
    von Seidlein L; Milligan P; Pinder M; Bojang K; Anyalebechi C; Gosling R; Coleman R; Ude JI; Sadiq A; Duraisingh M; Warhurst D; Alloueche A; Targett G; McAdam K; Greenwood B; Walraven G; Olliaro P; Doherty T
    Lancet; 2000 Jan; 355(9201):352-7. PubMed ID: 10665554
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sulfadoxine specific lymphocyte transformation in a patient with eosinophilic pneumonia induced by sulfadoxine-pyrimethamine (Fansidar).
    Daniel PT; Holzschuh J; Berg PA
    Thorax; 1989 Apr; 44(4):307-9. PubMed ID: 2763233
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania.
    Mutabingwa T; Nzila A; Mberu E; Nduati E; Winstanley P; Hills E; Watkins W
    Lancet; 2001 Oct; 358(9289):1218-23. PubMed ID: 11675058
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Eosinophilic lung infiltration during malaria prophylaxis with pyrimethamine-sulfadoxine (Fansidar)].
    Buser P; Räber J
    Schweiz Med Wochenschr; 1985 Aug; 115(34):1174-6. PubMed ID: 4048913
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sulfadoxine-pyrimethamine resistance and intermittent preventive treatment during pregnancy: a retrospective analysis of birth weight data in the Democratic Republic of Congo (DRC).
    Likwela JL; D'Alessandro U; Lokwa BL; Meuris S; Dramaix MW
    Trop Med Int Health; 2012 Mar; 17(3):322-9. PubMed ID: 22212628
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mortality, Morbidity, and Developmental Outcomes in Infants Born to Women Who Received Either Mefloquine or Sulfadoxine-Pyrimethamine as Intermittent Preventive Treatment of Malaria in Pregnancy: A Cohort Study.
    Rupérez M; González R; Mombo-Ngoma G; Kabanywanyi AM; Sevene E; Ouédraogo S; Kakolwa MA; Vala A; Accrombessi M; Briand V; Aponte JJ; Manego Zoleko R; Adegnika AA; Cot M; Kremsner PG; Massougbodji A; Abdulla S; Ramharter M; Macete E; Menéndez C
    PLoS Med; 2016 Feb; 13(2):e1001964. PubMed ID: 26905278
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adverse reactions to pyrimethamine/sulfadoxine.
    Koch-Weser J; Hodel C; Leimer R; Styk S
    Lancet; 1982 Dec; 2(8313):1459. PubMed ID: 6129527
    [No Abstract]   [Full Text] [Related]  

  • 59. Impact of a double dose of sulphadoxine-pyrimethamine to reduce prevalence of pregnancy malaria in southern Mozambique.
    Challis K; Osman NB; Cotiro M; Nordahl G; Dgedge M; Bergström S
    Trop Med Int Health; 2004 Oct; 9(10):1066-73. PubMed ID: 15482398
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term outcome of children with congenital toxoplasmosis.
    Berrébi A; Assouline C; Bessières MH; Lathière M; Cassaing S; Minville V; Ayoubi JM
    Am J Obstet Gynecol; 2010 Dec; 203(6):552.e1-6. PubMed ID: 20633868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.